Skip to main content
Pengchuang Zhang on Muck Rack

Pengchuang Zhang

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pengchuang

Contact Pengchuang, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Survival outcomes of low-dose and high-dose bevacizumab front-line maintenance in advanced high-grade serous ovarian cancer: a propensity score-matched real-world study

|
By Tao Wu, Yahui Shen, Xiaowei Wang, Lijuan Hu, Jianrong Lu, Guoqing Wang, Pengchuang Zhang
| Frontiers
Abstract Background: The optimal dose of bevacizumab for first-line maintenance therapy in advanced ovarian high-grade serous carcinoma (HGSC) remains controversial due to the lack of head-to-head RCTs. This real-world study aimed to compare the efficacy and safety of low-dose (7.5 mg/kg every 3 weeks) and high-dose (15 mg/kg every 3 weeks) bevacizumab in this population.
Open in Who Shared Issue with article?
See all 1 articles